Redwood City, CA, United States of America

Maksim Osipov

This inventor holds 24 USPTO granted patents and 23 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Denali Therapeutics Inc., Flexus Biosciences, Inc., Bristol-Myers Squibb Compnay. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maksim Osipov. Retrieved from https://idiyas.com/inventor/maksim-osipov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 23)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 20)

EPO Patents = 7 (Patent Applications = 31)

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 38(Granted Patents)

Location History:

South San Francisco, CA (US) (2021)
South San Franscisco, CA (US) (2021 - 2023)
Belmont, CA (US) (2017 - 2024)
Redwood City, CA (US) (2019 - 2024)

Company Filing History:

12 out of 57

Denali Therapeutics Inc.

patents

8 out of 8

Flexus Biosciences, Inc.

patents

4 out of 3,745

Bristol-Myers Squibb Compnay

patents

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

IDO Inhibitors

Kinase Inhibitors

Immunoregulatory Agents

Quinolinylcyclohexylpropanamide

Eukaryotic Initiation Factor

Compositions

Methods

Pharmaceuticals

Compounds

Therapeutics

Drug Development

Biotechnology

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421195 - Amorphous and crystalline forms of IDO inhibitors (2025-09-23),

2. 12180211 - Compounds, compositions and methods (2024-12-31),

3. 12139478 - Compounds, compositions and methods (2024-11-12),

4. 12129263 - Kinase inhibitors and uses thereof (2024-10-29),

5. 12091392 - Compounds, compositions and methods (2024-09-17),

6. 11958840 - Compounds, compositions and methods (2024-04-16),

7. 11932601 - Immunoregulatory agents (2024-03-19),

8. 11919863 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2024-03-05),

9. 11851440 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2023-12-26),

10. 11851433 - Compounds, compositions and methods (2023-12-26),

11. 11306077 - Compounds, compositions and methods (2022-04-19),

12. 11242319 - Immunoregulatory agents (2022-02-08),

13. 11236100 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2022-02-01),

14. 11236049 - Amorphous and crystalline forms of IDO inhibitors (2022-02-01),

15. 11236048 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2022-02-01),

Title: The Innovative Journey of Maksim Osipov

Introduction: Maksim Osipov is a visionary inventor based in Redwood City, CA, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Maksim Osipov holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Maksim Osipov has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Maksim Osipov has collaborated with top research institutions, leading companies, and brilliant minds from around the world to bring his ideas to life and make a lasting impact.

Conclusion: Maksim Osipov's relentless pursuit of innovation and his dedication to creating a better future through his inventions make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.